000 | 00985 a2200289 4500 | ||
---|---|---|---|
005 | 20250516125136.0 | ||
264 | 0 | _c20130607 | |
008 | 201306s 0 0 eng d | ||
022 | _a1744-8379 | ||
024 | 7 |
_a10.1586/erp.12.66 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aUsher, Cara | |
245 | 0 | 0 |
_aA reference pricing system for Ireland. _h[electronic resource] |
260 |
_bExpert review of pharmacoeconomics & outcomes research _cDec 2012 |
||
300 |
_a675-7 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 | _aCost Control |
650 | 0 | 4 | _aDrug Costs |
650 | 0 | 4 |
_aDrug Substitution _xeconomics |
650 | 0 | 4 |
_aDrugs, Generic _xeconomics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIreland |
650 | 0 | 4 |
_aReimbursement Mechanisms _xeconomics |
700 | 1 | _aBarry, Michael | |
773 | 0 |
_tExpert review of pharmacoeconomics & outcomes research _gvol. 12 _gno. 6 _gp. 675-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1586/erp.12.66 _zAvailable from publisher's website |
999 |
_c22357763 _d22357763 |